Medimaps Group is a leading global medical software analytics company founded by a group of clinical practitioners and researchers, based in Switzerland with offices in the US and in France. It specialises in the engineering, research, development, and commercialisation of medical software applications based on patented multi-purpose technologies.
Its flagship product, the TBS iNsight™ (Osteo) software application has been used for years in clinical practice to better predict fracture risk in the field of osteoporosis. It has become the gold standard for bone structure assessment in routine clinical practice.
This core technology has been further developed and new medical applications have been created in the dental and orthopaedics fields. Medimaps is also exploring applications in veterinary medicine and oncology.